2013
DOI: 10.1371/journal.pone.0076235
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Novel Predictor Classifiers for Inflammatory Bowel Disease by Gene Expression Profiling

Abstract: BackgroundImprovement of patient quality of life is the ultimate goal of biomedical research, particularly when dealing with complex, chronic and debilitating conditions such as inflammatory bowel disease (IBD). This is largely dependent on receiving an accurate and rapid diagnose, an effective treatment and in the prediction and prevention of side effects and complications. The low sensitivity and specificity of current markers burden their general use in the clinical practice. New biomarkers with accurate pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
39
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(40 citation statements)
references
References 23 publications
0
39
0
Order By: Relevance
“…(Supplementary Tables 9-10). In particular, 136 (UC) and 246 (CD) transcripts known to be involved in positive regulation of cytokine production were overexpressed in inflamed mucosa, including pathways for the production of IL-1, IL-2, IL-4, IL-6, IL-8/CXCL8, IL-10, IFNγ, and TNF, which were also upregulated in other IBD studies 29,30 . Furthermore, 118 (UC) and 118 (CD) transcripts were enriched for the defense response to other organisms, 51 (UC) and 108 (CD) transcripts were involved in the response to lipopolysaccharide, and 113 (UC) and 46 (CD) transcripts for the response to molecules of bacterial origin, all indicating a pathogenesis Fig.…”
Section: Inflammation-related Host Expression and In Vitro Validationmentioning
confidence: 83%
“…(Supplementary Tables 9-10). In particular, 136 (UC) and 246 (CD) transcripts known to be involved in positive regulation of cytokine production were overexpressed in inflamed mucosa, including pathways for the production of IL-1, IL-2, IL-4, IL-6, IL-8/CXCL8, IL-10, IFNγ, and TNF, which were also upregulated in other IBD studies 29,30 . Furthermore, 118 (UC) and 118 (CD) transcripts were enriched for the defense response to other organisms, 51 (UC) and 108 (CD) transcripts were involved in the response to lipopolysaccharide, and 113 (UC) and 46 (CD) transcripts for the response to molecules of bacterial origin, all indicating a pathogenesis Fig.…”
Section: Inflammation-related Host Expression and In Vitro Validationmentioning
confidence: 83%
“…Downstream of the MAPK and IκB‐NF‐κB pathways in activated mast cells, numerous transcription factors (e.g., Egr, NF‐κB, NFAT) are activated and direct de novo gene expression of cytokines and chemokines that direct the inflammatory events at the site, including immune cell recruitment and activation 56‐58 . Gene expression profiles are commonly recognized as a viable predictor in prognosis, severity, and survival in patients suffering from various inflammatory diseases including inflammatory bowel disease, 59 multiple myeloma, 60 and some cancers including esophageal squamous cell carcinoma and HPV associated tumors, 61,62 among many others. Previous research has measured TNF mRNA expression levels as an indicator for allergic inflammation severity in the airways 56 .…”
Section: Discussionmentioning
confidence: 99%
“…We firstly explored UC and CRC related data in Gene Expression Omnibus (GEO) and Array Express (AE) database, then screened these data with similar conditions (such as possessing normal controls, total RNA obtained from intestinal biopsies and clear sample descriptions), and finally six microarray expression profiles (GSE36807 [13], GSE38713 [14], GSE6731 [15], GSE4183 [16], GSE41258 [17] and E-MTAB-57 [18]) were selected. There were total 90 UC patients and 24 normal controls for UC analysis, while a total of 350 CRC patients and 140 normal controls were used.…”
Section: Methodsmentioning
confidence: 99%